Home / Companies / Haisco Pharmaceutical Group Co., Ltd. / 6 May 2026
Haisco Pharmaceutical Group Co., Ltd.: meeting of 6 May 2026
Votes reported on Form N-PX, item by item
24 Form N-PX filers reported votes at the Haisco Pharmaceutical Group Co., Ltd. meeting of 6 May 2026. Their records fall into 8 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
37 vote records from 23 filers. 0 of the 23 filers that marked the item either way voted against management.
EXTRAORDINARY TRANSACTIONSIssuer
EXTRAORDINARY TRANSACTIONS: management items
Management items in this category are shown together; filers word and number them differently.
32 vote records from 18 filers. 0 of the 18 filers that marked the item either way voted against management.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
58 vote records from 24 filers. 1 of the 24 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
75 vote records from 24 filers. 0 of the 24 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
105 vote records from 20 filers. 0 of the 20 filers that marked the item either way voted against management.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
20 vote records from 4 filers. 0 of the 4 filers that marked the item either way voted against management.
CAPITAL STRUCTURESecurity holder
Approve Authorization of Board to Handle All Related Matters
28 vote records from 16 filers. 0 of the 16 filers that marked the item either way voted against management.
CAPITAL STRUCTURESecurity holder
Approve Extension of Resolution Validity Period for Share Issuance
28 vote records from 16 filers. 0 of the 16 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Auditor | 7. Proposal | 8. Proposal |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | No report | No report |
| Fidelity | For | For | For |
| Dimensional | For | For | For |
| State Street and SPDR | For | For | For |
| Franklin Templeton | For | For | For |
| Charles Schwab | For | No report | No report |
| Nuveen and TIAA | For | For | For |
| John Hancock and Manulife | For | No report | No report |
| J.P. Morgan | For | For | For |
| Goldman Sachs | For | For | For |
| Jackson National funds | For | No report | No report |
| Northern Trust and FlexShares | For | For | For |
| Pacific Life funds | For | For | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Haisco Pharmaceutical Group Co., Ltd. meeting?
24 Form N-PX filers reported votes at the meeting of 6 May 2026. 2 proposals from security holders could be told apart in the filings. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Haisco Pharmaceutical Group Co., Ltd. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Haisco Pharmaceutical Group Co., Ltd.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Haisco Pharmaceutical Group Co., Ltd. with a meeting date within three days of 6 May 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.